MetLife Investment Management LLC Cuts Stake in HCA Healthcare, Inc. $HCA

Key Points

• MetLife Investment Management LLC reduced its stake in HCA Healthcare by 3.6%, holding 48,529 shares worth approximately $16.77 million as of the latest filing.
• HCA Healthcare reported earnings of $6.84 per share, surpassing estimates, with quarterly revenues of $18.61 billion, marking a 6.4% year-over-year increase.
• The company declared a quarterly dividend of $0.72 per share, which will be paid on September 30th, representing an annual yield of 0.7%.

MetLife Investment Management LLC reduced its position in shares of HCA Healthcare, Inc. (NYSE:HCA - Free Report) by 3.6% in the 1st quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 48,529 shares of the company's stock after selling 1,790 shares during the period. MetLife Investment Management LLC's holdings in HCA Healthcare were worth $16,769,000 at the end of the most recent reporting period.

Several other institutional investors also recently modified their holdings of the business. Cheviot Value Management LLC bought a new stake in HCA Healthcare during the first quarter valued at $26,000. Atwood & Palmer Inc. acquired a new stake in shares of HCA Healthcare in the 1st quarter worth about $28,000. Bartlett & CO. Wealth Management LLC lifted its position in shares of HCA Healthcare by 888.9% during the 1st quarter. Bartlett & CO. Wealth Management LLC now owns 89 shares of the company's stock worth $31,000 after buying an additional 80 shares in the last quarter. ORG Partners LLC grew its position in shares of HCA Healthcare by 344.0% during the 1st quarter. ORG Partners LLC now owns 111 shares of the company's stock valued at $38,000 after acquiring an additional 86 shares during the period. Finally, Migdal Insurance & Financial Holdings Ltd. grew its position in shares of HCA Healthcare by 75.8% during the 1st quarter. Migdal Insurance & Financial Holdings Ltd. now owns 116 shares of the company's stock valued at $40,000 after acquiring an additional 50 shares during the period. Institutional investors own 62.73% of the company's stock.

Analyst Ratings Changes

Several research analysts have commented on the company. Morgan Stanley cut their target price on HCA Healthcare from $410.00 to $400.00 and set an "equal weight" rating for the company in a research note on Monday, July 28th. Bank of America cut shares of HCA Healthcare from a "buy" rating to a "neutral" rating and set a $394.00 target price on the stock. in a research report on Wednesday, July 16th. Truist Financial boosted their price objective on shares of HCA Healthcare from $390.00 to $415.00 and gave the company a "buy" rating in a research report on Wednesday, July 16th. Royal Bank Of Canada reduced their price target on shares of HCA Healthcare from $404.00 to $401.00 and set an "outperform" rating on the stock in a research report on Monday, July 28th. Finally, Barclays dropped their price objective on shares of HCA Healthcare from $416.00 to $390.00 and set an "overweight" rating on the stock in a research note on Monday, July 28th. One investment analyst has rated the stock with a Strong Buy rating, seven have issued a Buy rating and nine have assigned a Hold rating to the company's stock. According to MarketBeat.com, the company currently has a consensus rating of "Moderate Buy" and a consensus price target of $401.83.

HCA Healthcare Stock Performance

HCA Healthcare stock traded down $3.17 during midday trading on Friday, hitting $404.11. The stock had a trading volume of 988,440 shares, compared to its average volume of 1,546,339. The company has a current ratio of 0.98, a quick ratio of 0.86 and a debt-to-equity ratio of 69.07. HCA Healthcare, Inc. has a 52-week low of $289.98 and a 52-week high of $417.14. The firm's fifty day moving average is $376.38 and its two-hundred day moving average is $356.08. The company has a market capitalization of $94.56 billion, a PE ratio of 16.99, a P/E/G ratio of 1.27 and a beta of 1.39.

HCA Healthcare (NYSE:HCA - Get Free Report) last posted its earnings results on Friday, July 25th. The company reported $6.84 EPS for the quarter, beating analysts' consensus estimates of $6.20 by $0.64. The firm had revenue of $18.61 billion during the quarter, compared to the consensus estimate of $18.49 billion. HCA Healthcare had a negative return on equity of 7,363.11% and a net margin of 8.21%.The company's quarterly revenue was up 6.4% compared to the same quarter last year. During the same period in the prior year, the company earned $5.50 EPS. HCA Healthcare has set its FY 2025 guidance at 25.500-27.000 EPS. On average, research analysts forecast that HCA Healthcare, Inc. will post 24.98 EPS for the current year.

HCA Healthcare Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Tuesday, September 30th. Stockholders of record on Tuesday, September 16th will be given a dividend of $0.72 per share. This represents a $2.88 annualized dividend and a dividend yield of 0.7%. The ex-dividend date is Tuesday, September 16th. HCA Healthcare's dividend payout ratio (DPR) is 12.11%.

About HCA Healthcare

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.